Fontolizumab: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Fontolizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(No difference)
|
Latest revision as of 20:20, 27 September 2011
Template:Drugbox-mab Fontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |